J&J obtains FDA clearance for wider use of Prezista

The FDA approved Johnson & Johnson's HIV drug Prezista for use with Abbott Laboratories' Norvir in newly diagnosed patients. Prezista, a protease inhibitor, already had approval for use in patients who developed resistance to other therapies.

View Full Article in:

Wall Street Journal (tiered subscription model), The · Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA